Australia markets open in 5 hours 4 minutes

AVDL Jan 2025 12.500 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
4.45000.0000 (0.00%)
As of 12:56PM EDT. Market open.
Full screen
Previous close4.4500
Open4.4500
Bid3.8000
Ask4.1000
Strike12.50
Expiry date2025-01-17
Day's range4.4500 - 4.4500
Contract rangeN/A
Volume16
Open interest1.67k
  • Zacks

    Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?

    Harrow (HROW) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

  • GlobeNewswire

    Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

    DUBLIN, May 30, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the following upcoming investor conferences: Jefferies Global Healthcare Conference: Fireside chat on Thursday, June 6 at 10:30 a.m. ET.Goldman Sachs 45th Annual Global Healthcare Conference: Fireside chat on Wednesday, June 12 at 3:20 p.m. ET. A live webcast of these ev

  • GlobeNewswire

    Avadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024

    – 11 accepted abstracts, including new data reiterating satisfaction, preference and clinical benefit of LUMRYZ – – Presentations highlight Avadel’s continued commitment to address gaps in narcolepsy care – DUBLIN, May 22, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, announced today it will present 11 posters, and one oral presentation, supporting the use of LUMRYZ as a narcolepsy treatment option at SLEEP 202